Bryan Larson Bryan Larson

More Than Drug Discovery: AI in Biotech and Pharmaceuticals

We’re on the cusp of realizing true augmented intelligence. In data-heavy industries with a lot at stake, AI could reduce cost, operationalize the process, assist in scale, and reduce error. Nowhere is this more apparent than the process of drug discovery.

Read More